By Kristy Dorsey

Healthcare software provider Craneware said it has seen a return to strong sales growth during the four months to the end of October following the market disruption caused by the onset of the coronavirus pandemic earlier this year.

In a statement issued ahead of the company’s annual general meeting, the company said sales in the first four months of the financial year were “considerably ahead” of the same period in 2019.

“Results are ahead of management expectations for this stage in the year and, we expect revenues and adjusted EBITDA for the interim period to 31 December 2020 to be ahead of the equivalent period in the prior year, building the foundation for a return to double-digit growth in the future,” directors added.

READ MORE: Scottish healthcare software company hails ‘strong sales momentum’ in US

Headquartered in Edinburgh, Craneware sells billing and financial management software to healthcare providers located mainly in the United States. The company employs 350 people across its offices in Atlanta, Pittsburgh and the Scottish capital.

For the year to the end of June, Craneware reported a 5 per cent increase in both earnings and profits. This was despite the difficulties imposed by the Covid-19 pandemic in the final quarter of the financial year.

The company said its Trisus platform “continues to resonate” with the leadership teams of US hospitals. Trisus provides the means to collect, verify and correct data so hospitals can improve their financial and operational performance.

READ MORE: Scottish software firm Craneware halts £80m fundraising after US firm sells to another suitor

“With each hospital that joins the platform, Trisus becomes more powerful,” Craneware said. “Through the recent beta launches of the Trisus (cloud) versions of our core offerings, Chargemaster Toolkit and Pharmacy Chargelink, and our four live Trisus native cloud applications, we now have multiple means by which new and existing customers can join the Trisus community, providing them with a gateway to the wider benefits the platform can provide.”

Shares in Craneware closed nearly 12% higher yesterday at 2,150p.